Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2026-01-22 @ 10:40 AM
Study NCT ID:
NCT01821859
Status:
TERMINATED
Last Update Posted:
2013-07-26
First Post:
2013-03-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Abraxane/Bevacizumab
Sponsor:
OHSU Knight Cancer Institute
Organization: